Clinical Trial Update: MS-20 on Patients With Ulcerative Colitis(UC) [NA]

View source ↗

Summary

MS-20 is being evaluated in patients with Ulcerative Colitis and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• MS-20

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Ulcerative Colitis | NA | Status: RECRUITING